- Home
- SLAI vs QNRX Comparison
SLAI vs QNRX Comparison
Compare SLAI & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SLAI
SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)
Current Price
Current Price
Company Overview
Basic Information| Metric | SLAI | QNRX |
|---|---|---|
| Founded | 2001 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5M | 14.5M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | SLAI | QNRX |
|---|---|---|
| Price | $0.87 | $6.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 74.9K | ★ 122.4K |
| Earning Date | 05-01-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $5.47 |
| 52 Week High | $2.55 | $41.80 |
Technical Indicators
Market Signals| Indicator | SLAI | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.28 | 40.52 |
| Support Level | $0.81 | $5.47 |
| Resistance Level | $1.15 | $10.42 |
| Average True Range (ATR) | 0.06 | 0.67 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 62.75 | 38.65 |
Price Performance
Historical ComparisonAbout SLAI SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)
SOLAI Ltd is a technology-driven cryptocurrency infrastructure company. It is expanding from its foundation in crypto mining to build a blockchain-based ecosystem spanning AI, stablecoins, and payment infrastructure, and Solana treasury and staking operations supporting use cases across institutional settlement, commerce, consumer payments, and AI-native agent transactions. The group is leveraging its blockchain and data infrastructure expertise, aiming to enhance on-chain efficiency and expand participation across Solana and other blockchain ecosystems.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.